Learn More
Description
Reacts with an 80-90 kDa, mucin-like molecule present on CD34+ cells during the early stages of B cell, erythroid cell and myelomonocytic cell development. It is also expressed on epithelial cells, peripheral blood monocytes and weakly on lymphocytes. Mucin-like molecules are a new family of glycoproteins present in tissues of the hematopoietic system. They are highly glycosylated polypeptides, containing predominantly O-linked carbohydrate side chains. Reports suggest that CD164 may play a role in hematopoiesis by facilitating the adhesion of CD34+ cells to bone marrow stroma.
This antibody is routinely tested by flow cytrometric analysis. Other applications were tested at BD Bioscience Pharmingen during antibody development only or reported in the literature.
Specifications
Specifications
| Antigen | CD164 |
| Applications | Flow Cytometry |
| Classification | Monoclonal |
| Clone | N6B6 |
| Concentration | 0.5mg/mL |
| Conjugate | Unconjugated |
| Formulation | Aqueous buffered solution containing ≤0.09% sodium azide. |
| Host Species | Mouse |
| Immunogen | Human Pre-B Cell Line |
| Purification Method | Affinity Purified |
| Show More |
For Research Use Only.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.